These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34954416)

  • 1. Encapsulation of doxorubicin prodrug in heat-triggered liposomes overcomes off-target activation for advanced prostate cancer therapy.
    Pereira S; Ma G; Na L; Hudoklin S; Kreft ME; Kostevsek N; Al-Jamal WT
    Acta Biomater; 2022 Mar; 140():530-546. PubMed ID: 34954416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Toward Prodrug-Nanomedicine Design.
    Pereira SGT; Hudoklin S; Kreft ME; Kostevsek N; Stuart MCA; Al-Jamal WT
    Mol Pharm; 2019 Apr; 16(4):1573-1585. PubMed ID: 30802065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dually targeted bioinspired nanovesicle delays advanced prostate cancer tumour growth in vivo.
    Ma G; Severic M; Barker M; Pereira S; Ruiz A; Cheung CCL; Al-Jamal WT
    Acta Biomater; 2021 Oct; 134():559-575. PubMed ID: 34274531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
    Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
    J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo activity of a PSA-activated doxorubicin prodrug against PSA-producing human prostate cancer xenografts.
    Khan SR; Denmeade SR
    Prostate; 2000 Sep; 45(1):80-3. PubMed ID: 10960846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia.
    Al-Jamal WT; Al-Ahmady ZS; Kostarelos K
    Biomaterials; 2012 Jun; 33(18):4608-17. PubMed ID: 22459195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focused Ultrasound Hyperthermia Mediated Drug Delivery Using Thermosensitive Liposomes and Visualized With
    Santos MA; Goertz DE; Hynynen K
    Theranostics; 2017; 7(10):2718-2731. PubMed ID: 28819458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthermia-triggered drug delivery from iRGD-modified temperature-sensitive liposomes enhances the anti-tumor efficacy using high intensity focused ultrasound.
    Deng Z; Xiao Y; Pan M; Li F; Duan W; Meng L; Liu X; Yan F; Zheng H
    J Control Release; 2016 Dec; 243():333-341. PubMed ID: 27984104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy.
    Garsky VM; Lumma PK; Feng DM; Wai J; Ramjit HG; Sardana MK; Oliff A; Jones RE; DeFeo-Jones D; Freidinger RM
    J Med Chem; 2001 Nov; 44(24):4216-24. PubMed ID: 11708923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and characterisation of ultrasound imageable heat-sensitive liposomes for HIFU therapy.
    Maples D; McLean K; Sahoo K; Newhardt R; Venkatesan P; Wood B; Ranjan A
    Int J Hyperthermia; 2015; 31(6):674-85. PubMed ID: 26185910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).
    Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR
    J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo.
    Wang C; Wang X; Zhong T; Zhao Y; Zhang WQ; Ren W; Huang D; Zhang S; Guo Y; Yao X; Tang YQ; Zhang X; Zhang Q
    Int J Nanomedicine; 2015; 10():2229-48. PubMed ID: 25834435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours.
    Yarmolenko PS; Zhao Y; Landon C; Spasojevic I; Yuan F; Needham D; Viglianti BL; Dewhirst MW
    Int J Hyperthermia; 2010; 26(5):485-98. PubMed ID: 20597627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel two-step mild hyperthermia for advanced liposomal chemotherapy.
    Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA
    J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulated doxorubicin crystals influence lysolipid temperature-sensitive liposomes release and therapeutic efficacy in vitro and in vivo.
    Ruiz A; Ma G; Seitsonen J; Pereira SGT; Ruokolainen J; Al-Jamal WT
    J Control Release; 2020 Dec; 328():665-678. PubMed ID: 32961247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI Monitoring of Tumor-Selective Anticancer Drug Delivery with Stable Thermosensitive Liposomes Triggered by High-Intensity Focused Ultrasound.
    Kim HR; You DG; Park SJ; Choi KS; Um W; Kim JH; Park JH; Kim YS
    Mol Pharm; 2016 May; 13(5):1528-39. PubMed ID: 26998616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
    Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
    J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild hyperthermia accelerates doxorubicin clearance from tumour-extravasated temperature-sensitive liposomes.
    Al-Jamal WT; Kostarelos K
    Nanotheranostics; 2022; 6(3):230-242. PubMed ID: 35145834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of an albumin-binding prodrug of doxorubicin that is cleaved by prostate-specific antigen (PSA) in a PSA-positive orthotopic prostate carcinoma model (LNCaP).
    Graeser R; Chung DE; Esser N; Moor S; Schächtele C; Unger C; Kratz F
    Int J Cancer; 2008 Mar; 122(5):1145-54. PubMed ID: 17973264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.